ELISA methods comparison for the detection of auto-antibodies against apolipoprotein A1.

作者: Miguel A. Frias , Julien Virzi , Joana Batuca , Sabrina Pagano , Natahlie Satta

DOI: 10.1016/J.JIM.2019.03.011

关键词:

摘要: Abstract Background Autoantibodies against apolipoprotein A1 (anti-apoA1 IgG) have emerged as an independent biomarker for cardiovascular disease and mortality. Across studies, different ELISA methods been used to measure the level of circulating anti-apoA1 IgG which could lead substantial result differences between assays. Objectives To make a comparative study available detection determine whether choice matrix sample (serum vs plasma) influence results. Methods Blood samples were obtained from 160 healthy blood donors collected on 4 matrixes (serum, plasma-EDTA, -citrate, -lithium-heparinate). Anti-apoA1 was measured using two homemade (Geneva's Lisbon's) one commercial kits. Passing-Bablok Bland-Altman compare seropositivity cut-offs defined according user's/manufacturer's criterion. Results The current results showed those 3 dynamic ranges significantly different, kit displaying narrowest one. analysis demonstrated important proportional constant biases rate in Geneva, Lisbon assays varied 24.5% 1.9%. Matrix comparisons that (plasma versus serum) influenced well assay-dependent manner. coating antigen source identified factor underlying heterogeneity across Conclusions These highlight impact method cut-off emphasize need standardizing existing Given influence, we suggest use serum choice.

参考文章(33)
Darcy S. Majka, Rowland W. Chang, Is preclinical autoimmunity benign?: The case of cardiovascular disease. Rheumatic Diseases Clinics of North America. ,vol. 40, pp. 659- 668 ,(2014) , 10.1016/J.RDC.2014.07.006
Nicolas Vuilleumier, Fabrizio Montecucco, Oliver Hartley, Autoantibodies to apolipoprotein A-1 as a biomarker of cardiovascular autoimmunity World Journal of Cardiology. ,vol. 6, pp. 314- 326 ,(2014) , 10.4330/WJC.V6.I5.314
Alexander Marson, William J. Housley, David A. Hafler, Genetic basis of autoimmunity Journal of Clinical Investigation. ,vol. 125, pp. 2234- 2241 ,(2015) , 10.1172/JCI78086
Sabrina Pagano, Hubert Gaertner, Fabrice Cerini, Tiphaine Mannic, Nathalie Satta, Priscila Camillo Teixeira, Paul Cutler, François Mach, Nicolas Vuilleumier, Oliver Hartley, The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? PLOS ONE. ,vol. 10, ,(2015) , 10.1371/JOURNAL.PONE.0132780
S. Pagano, N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine. ,vol. 272, pp. 344- 357 ,(2012) , 10.1111/J.1365-2796.2012.02530.X
J. H. Humphreys, A. Warner, J. Chipping, T. Marshall, M. Lunt, D. P. M. Symmons, S. M. M. Verstappen, Mortality Trends in Patients With Early Rheumatoid Arthritis Over 20 Years: Results From the Norfolk Arthritis Register Arthritis Care and Research. ,vol. 66, pp. 1296- 1301 ,(2014) , 10.1002/ACR.22296
A R Dinu, J T Merrill, C Shen, I V Antonov, B L Myones, R G Lahita, Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus. ,vol. 7, pp. 355- 360 ,(1998) , 10.1191/096120398678920262
J. R. BATUCA, P. R. J. AMES, D. A. ISENBERG, J. DELGADO ALVES, Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus. Annals of the New York Academy of Sciences. ,vol. 1108, pp. 137- 146 ,(2007) , 10.1196/ANNALS.1422.016
Nicolas Vuilleumier, Sylvette Bas, Sabrina Pagano, Fabrizio Montecucco, Pierre-André Guerne, Axel Finckh, Christian Lovis, François Mach, Denis Hochstrasser, Pascale Roux-Lombard, Cem Gabay, Anti–apolipoprotein A‐1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis Arthritis & Rheumatism. ,vol. 62, pp. 2640- 2650 ,(2010) , 10.1002/ART.27546